BriaCell Therapeutics

BriaCell Therapeutics BCTX Stock

$3.44   4.242427%
Add to favorites
Market Cap
$30.04M
LOW - HIGH [24H]
$3.27 - $3.44
VOLUME [24H]
$35.26K
P/E Ratio
0
Earnings per share
-$6.97
ISIN
CA1079303071
Price   Prediction

BriaCell Therapeutics Price Chart

Sorry, that's all we've gotfor now...

BriaCell Therapeutics (BCTX) stock price today is 3.44 USD on Tech Market Small (+4.24% on the day). Updated .

BriaCell Therapeutics BCTX Financial and Trading Overview

BriaCell Therapeutics stock price 3.44 USD
Previous Close 3.39 USD
Open 3.37 USD
Bid 3.44 USD x 100
Ask 3.71 USD x 100
Day's Range 3.29 - 3.44 USD
52 Week Range 2.6 - 13.09 USD
Volume 28.96K USD
Avg. Volume 258.28K USD
Market Cap 28.82M USD
Beta (5Y Monthly) 1.657
PE Ratio (TTM) N/A
EPS (TTM) -6.97 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

BCTX Valuation Measures

Enterprise Value 7.43M USD
Trailing P/E N/A
Forward P/E -8.461538
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.7525226
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.207

Trading Information

BriaCell Therapeutics Stock Price History

Beta (5Y Monthly) 1.657
52-Week Change -57.99%
S&P500 52-Week Change 13.32%
52 Week High 13.09 USD
52 Week Low 2.6 USD
50-Day Moving Average 3.72 USD
200-Day Moving Average 3.76 USD

BCTX Share Statistics

Avg. Volume (3 month) 258.28K USD
Avg. Daily Volume (10-Days) 66.43K USD
Shares Outstanding 8.73M
Float 7.96M
Short Ratio 13.01
% Held by Insiders 0.13%
% Held by Institutions 5.34%
Shares Short 807.64K
Short % of Float 9.25%
Short % of Shares Outstanding 9.25%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends July 31, 2026
Most Recent Quarter (mrq) July 31, 2026
Next Fiscal Year End July 31, 2027

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -99.64%
Return on Equity (ttm) -214.78%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -35934904 USD
Net Income Avi to Common (ttm) -34904264 USD
Diluted EPS (ttm) -6.97
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 20.54M USD
Total Cash Per Share (mrq) 2.35 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.762
Book Value Per Share (mrq) 1.883

Cash Flow Statement

Operating Cash Flow (ttm) -28651324 USD
Levered Free Cash Flow (ttm) -16265016 USD

Profile of BriaCell Therapeutics

Country United States
State BC
City West Vancouver
Address Bellevue Centre
ZIP V7T 2X1
Phone 604-921-1810
Website https://briacell.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 31

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. The company is headquartered in West Vancouver, Canada.

Q&A For BriaCell Therapeutics Stock

What is a current BCTX stock price?

BriaCell Therapeutics BCTX stock price today per share is 3.44 USD.

How to purchase BriaCell Therapeutics stock?

You can buy BCTX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BriaCell Therapeutics?

The stock symbol or ticker of BriaCell Therapeutics is BCTX.

Which industry does the BriaCell Therapeutics company belong to?

The BriaCell Therapeutics industry is Biotechnology.

How many shares does BriaCell Therapeutics have in circulation?

The max supply of BriaCell Therapeutics shares is 8.73M.

What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?

BriaCell Therapeutics PE Ratio is now.

What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?

BriaCell Therapeutics EPS is -6.97 USD over the trailing 12 months.

Which sector does the BriaCell Therapeutics company belong to?

The BriaCell Therapeutics sector is Healthcare.

BriaCell Therapeutics BCTX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24245.71 USD —
-1.08
3.77B USD — 23989.09 USD — 24547.66 USD — — 3.77B USD —
$2.21T
Total marketcap
$77.05B
Total volume
BTC 58.49%   •   ETH 9.89%
Dominance
Select currency